Travere Therapeutics (TVTX)

• Market cap: $2.8B
• 1 day: -5.92%
• 5 days: -9.4%
• 1 month: 22.86%
• 3 months: 85.27%
• 6 months: 54.87%
• Year to date: 65.16%
• 1 year: 77.41%
• 5 years: 38.26%
• 10 years: 63.6%
• Sector: Healthcare
• Industry: Biotechnology

About: Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Employees: 385